Wikidata

(Q37496425)

English

Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer

scientific article published on 26 May 2009

In more languages

Statements

title
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017
author name string
William J Gradishar
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017
Dimitry Krasnojon
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017
Sergey Cheporov
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017
Anatoly N Makhson
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017
Georgiy M Manikhas
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017
Alicia Clawson
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017
page(s)
3611-3619
1 reference
stated in
Europe PubMed Central
PubMed ID
19470941
retrieved
20 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q37496425&oldid=2131342592"